Cargando…
A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus
Anti-adrenergic therapy has been widely accepted as an important therapeutic intervention in patients with chronic heart failure. However, there has been continuing controversy regarding the risks and clinical significance of metabolic effects of different anti-adrenergic drugs. This review summariz...
Autor principal: | Wilson Tang, WH |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291308/ https://www.ncbi.nlm.nih.gov/pubmed/18078015 |
Ejemplares similares
-
Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure
por: Perez, Dianne M.
Publicado: (2021) -
Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling
por: Femminella, Grazia Daniela, et al.
Publicado: (2014) -
Recent advances in treatment of heart failure
por: Kitai, Takeshi, et al.
Publicado: (2015) -
Diabetes Mellitus and Heart Failure
por: Triposkiadis, Filippos, et al.
Publicado: (2021) -
Diabetes Mellitus and Heart Failure
por: Siao, Wun-Zhih, et al.
Publicado: (2022)